Warberg Asset Management’s bioAffinity Technologies BIAFW Stock Holding History

Warberg Asset Management’s Portfolio BIAFW Stock Details BIAFW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,476	Closed	-$5.94K	–	214
2024 Q2	$5.94K	Sell	14,476 -1,203	-8%	-$571	﹤0.01%	186
2024 Q1	$12K	Sell	15,679 -7,247	-32%	-$2.41K	﹤0.01%	163
2023 Q4	$1.88K	Hold	22,926	–	–	﹤0.01%	204
2023 Q3	$2.09K	Sell	22,926 -1,700	-7%	-$507	﹤0.01%	223
2023 Q2	$8.9K	Hold	24,626	–	–	﹤0.01%	185
2023 Q1	$7.39K	Buy	24,626 +5,200	+27%	+$1.94K	﹤0.01%	202
2022 Q4	$8.16K	Hold	19,426	–	–	﹤0.01%	211
2022 Q3	$7K	Buy	+19,426	New	+$20.1K	﹤0.01%	248

Other funds holding BIAFW

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Warberg Asset Management's BIAFW Position: Q3 2024 in Review

Warberg Asset Management sold out of bioAffinity Technologies (BIAFW) in Q3 2024, closing a stake of 14,476 shares — an estimated $5.94K sold.

Warberg Asset Management first reported a position in BIAFW in Q3 2022 and held it in 8 quarters. The position peaked at $12K in Q1 2024. 4 funds tracked by Wall St. Rank hold BIAFW as of Q3 2024.

Warberg Asset Management reported no remaining bioAffinity Technologies position as of Q3 2024 after selling out during the quarter.
Warberg Asset Management sold 14,476 bioAffinity Technologies shares in Q3 2024, an estimated $5.94K.
Warberg Asset Management first reported a position in bioAffinity Technologies in Q3 2022 and held it in 8 quarters.
Warberg Asset Management's bioAffinity Technologies position peaked at $12K in Q1 2024.
4 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2024.

Based on Warberg Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.